1) Bio always takes longer than you think, and bringing a product to market is a complex non-trivial task. They've made progress over the last few years, particularly with bringing newer tests such as Endo to the stage where they can be commercialised.
2) Corporate communications, particularly with the whole Sonic thing, have been poor. Management have not been convincing when it comes to commercialising P-D, and selling at a higher price and then participating in a cap raise at a lower price is not a good look.
If the launch today puts (2) to bed then that's fine with me.
PIQ Price at posting:
35.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)